JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by THOA, N. B.
Right arrow Articles by WEINER, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOA, N. B.
Right arrow Articles by WEINER, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
*DACTINOMYCIN
*DOPAMINE
*L-TYROSINE
Journal of Pharmacology And Experimental Therapeutics, Vol. 178, Issue 3, 442-449, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


ACCELERATION OF CATECHOLAMINE FORMATION IN THE GUINEA-PIG VAS DEFERENS AFTER HYPOGASTRIC NERVE STIMULATION: ROLES OF TYROSINE HYDROXYLASE AND NEW PROTEIN SYNTHESIS

NGUYEN B. THOA 1, DAVID G. JOHNSON 1, IRWIN J. KOPIN 1, and NORMAN WEINER 1

1 Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland; Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado

Stimulation of the hypogastric nerve vas deferens preparation in vitro is associated with increased formation of dopamine and norepinephrine from labeled tyrosine both during and after stimulation. After stimulation for one hour, no changes in tyrosine-14C uptake or endogenous tyrosine and norepinephrine levels are observed. Tyrosine hydroxylase activity of homogenates prepared from these stimulated vasa deferentia is unaltered. The increased activity of tyrosine hydroxylase in intact vas deferens after nerve stimulation does not seem to be related to increased availability of pterin co-factor since excess 6,7-dimethyltetrahydropterine does not abolish the effect. Puromycin decreases the formation of catecholamines from tyrosine in intact vasa deferentia and inhibits the increased synthesis associated with previous nerve stimulation, but does not affect tyrosine hydroxylase activity in homogenates prepared from this tissue. Furthermore, the effect of puromycin on norepinephrine synthesis is not a consequence of inhibition of protein synthesis or of any other general property of inhibitors of protein synthesis since neither cycloheximide, in doses which produce a comparable decrease in protein synthesis, nor actinomycin decreases norepinephrine synthesis. These results suggest that the augmented synthesis of catecholamines which occurs in sympathetic nerves after short-term stimulation is not the result of any change in the level of tyrosine hydroxylase or pterin co-factor. It is suggested that since puromycin contains a p-methoxytyrosine residue, it may produce its inhibition of catecholamine synthesis by interfering with tyrosine-14C entry into sympathetic nerve cells.

Submitted on October 29, 1970
Accepted on April 20, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.